Autopsy report · NCT04992052

Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty

“Poor Enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 2 months before it stopped.
• 52 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Northwell Health

Sponsor type

University, hospital or other

Conditions

Total Knee Replacement

Interventions

Bone wax

Participants

52

Sites

1

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (96% match in meaning)
• CPT-3 in Normal Pressure Hydrocephalus
  “Inadequate enrollment” (91% match in meaning)
• Tocilizumab for the Treatment of Behcet's Syndrome
  “low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.